Clinical Trial Update: Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for sitagliptin plus G-CSF in acute myocardial infarction (Phase 2/3) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Acute Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED